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Stem cells and their niche
Stem cells, in contrast to progenitor cells, harbor the 
unique ability to divide and generate additional stem cells 
(self-renew) and to produce progeny that diﬀ  erentiate 
into tissue-speciﬁ  c cells with deﬁ  ned physiological func-
tions. Th   ese properties make embryonic stem (ES) cells, 
induced pluripotent stem (iPS) cells [1,2] and tissue-
speciﬁ  c adult stem cells (aSCs) well suited for regenera-
tive medicine applications. Nevertheless, the clinical use 
of ES cells, iPS cells, and aSCs for cell-based therapies is 
hindered by a number of critical hurdles. In addition to 
the ethical considerations associated with the generation 
of ES cells, cell populations derived from totipotent ES 
and iPS cells have the potential to generate teratomas 
upon transplantation if the ﬁ   delity and eﬃ   ciency  of 
diﬀ  erentiation and enrichment protocols are not ideal. 
aSCs are intrinsically wired to diﬀ  erentiate eﬃ   ciently into 
cells from their tissue of origin. However, their relative 
infrequency in tissues and our limited under  standing of 
the parameters regulating their diﬀ  erentiation and self-
renewal currently precludes most aSC-based clinical 
applications. However, the medical potential of stem 
cells, speciﬁ  cally aSCs, can be realized by placing un-
precedented emphasis on elucidating the mechanisms 
governing their behavior and fate.
aSC regulation is largely attributed to dynamic bidirec-
tional interactions made with the tissue environment in 
the immediate vicinity of the cell, termed the ‘niche’ 
(Figure 1). First formally described in the fruit ﬂ  y, Droso-
phila [3,4], the stem cell niche, or microenvironment, is 
composed of both biochemical (growth factors, cyto-
kines, receptor ligands, and so on) and biophysical 
(matrix stiﬀ   ness, topography/architecture, ﬂ  uidity,  and 
so on) factors that act singly and in concert to continu-
ously modulate cell fate. Despite widespread recognition 
of its importance, our understanding of niche elements 
and their cell and molecular inﬂ  uence on aSCs is limiting. 
We can remedy this by adopting creative research 
approaches that allow systematic analysis of candidate 
niche factors and are amenable to screens to identify 
presently unrecognized niche elements. By advancing our 
understanding of stem cell niche regulation we can begin 
to envision regenerative medicine applications built on 
principles derived from fundamental niche biology.
Naturally derived (that is, collagen, ﬁ  brin, MatrigelTM) 
and synthetic (that is, polyethylene glycol, polyacryla  mide, 
nanoﬁ  bers) biomaterials can be designed and patterned 
down to minute detail, oﬀ  ering the possibility to engineer 
stem cell niches and test eﬀ  ects of putative biochemical 
and biophysical features on stem cell fate in culture. Using 
biomaterials as a design framework, our under  standing of 
niche composition and how components regulate stem 
cells is limited only by the imagination. In this review we 
will discuss two- and three-dimensional biomaterial 
approaches to deconvolve the niche and its regulatory 
eﬀ  ects, and we will provide several examples of clinical 
applications that may beneﬁ  t from biomaterials research.
Engineering two-dimensional stem cell 
microenvironments
Th  e native aSC niche is a three-dimensional entity, and 
ultimately the most representative culture model of any 
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In the body, tissue homeostasis is established and 
maintained by resident tissue-specifi  c adult stem 
cells (aSCs). Through preservation of bidirectional 
communications with the surrounding niche and 
integration of biophysical and biochemical cues, 
aSCs actively direct the regeneration of aged, injured 
and diseased tissues. Currently, the ability to guide 
the behavior and fate of aSCs in the body or in 
culture after prospective isolation is hindered by our 
poor comprehension of niche composition and the 
regulation it imposes. Two- and three-dimensional 
biomaterials approaches permit systematic analysis 
of putative niche elements as well as screening 
approaches to identify novel regulatory mechanisms 
governing stem cell fate. The marriage of stem cell 
biology with creative bioengineering technology 
has the potential to expand our basic understanding 
of stem cell regulation imposed by the niche and to 
develop novel regenerative medicine applications.
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dimensionality on cells is complex to study and a means to 
do this has yet to be fully realized, making two-dimensional 
biomaterials approaches to deconstruct and study indi-
vidual niche components particularly attrac  tive. Extrinsic 
regulation of aSCs by niche elements - including cell-cell 
contact mediators, secreted signaling factors, extracellular 
matrix (ECM), substrate stiﬀ   ness and topography, 
nutritional para  meters (O2, nutrients), pH, temperature, 
ﬂ  uid ﬂ  ow, mecha  nical stress (that is, cyclic strain) and even 
gravity - can all be probed in two-dimensions to generate a 
modular toolbox of stem cell regulation that can be used in 
future three-dimensional niche reconstruction [5]. While 
our focus here is extrinsic stem cell regulation, it should be 
noted that intrinsic regulation is fundamentally important 
and typically both intrinsic and extrinsic regulation act in 
concert to modu  late cell behavior [6]. In this section we 
will discuss several niche parameters and the approaches 
used to probe them in two dimensions using examples 
from the literature.
Exploring cell-cell interactions
Tissue regeneration requires resident aSCs to survey the 
status of the microenvironment and respond appro-
priately when alterations resulting from aging, injury or 
disease are detected. In addition to changes incurred by 
the surrounding ECM or the inﬂ  ux of circulating factors 
from the vasculature, aSC behavior is guided through 
direct and indirect interactions with cells in close juxta-
position. Employing a biomaterials-based approach allows 
for fundamental insight into the spatial and temporal 
nature of aSC interactions with the surrounding support 
cells in the resting microenvironment and dis  covery of 
how those relationships change upon tissue insult.
Typically, co-culture of two or more cell types in a 
culture dish is used to study cell-cell interactions, though 
it is notoriously diﬃ   cult to draw deﬁ  nitive conclusions 
about mechanism due to the complexity of the system. 
Rather than studying a heterogeneous mix of two cell 
types, clever biomaterials-based strategies were deve  loped 
to generate isolated cell ‘pairs’. Microﬂ  uidics technology 
[7] combined with patterning on polydimethylsiloxane 
(PDMS; a silicone polymer that can harden to a rubber-
like material) to create an array of cell ‘traps’ and a three-
step loading protocol, was used to create a grid contain-
ing hundreds of ‘co-culture’ replicates [8]. Spatially 
segregating the cell pairs enables the user to evaluate cell 
fate changes over time at the pair level. Physical isolation 
of two cell types can also be achieved using synthetic, 
polyethylene glycol (PEG) hydrogels or PDMS patterned 
with microwells [9-15]. Tunable PEG hydrogel provides 
the additional ﬂ  exibility to interrogate cell pairs while 
altering additional microenvironmental parameters such 
as matrix rigidity and ECM/ligand identity, density or 
mode of presentation (that is, tethered or soluble). 
Impor  tantly, these approaches are all amenable to high-
throughput screening and time-lapse microscopy to 
assess co-culture eﬀ  ects on stem cell behavior and fate 
changes over time, such as division resulting in sym-
metric or asymmetric self-renewal, diﬀ  erentiation  and 
changes in viability.
To investigate whether observed co-culture behaviors 
are contingent on the direct interaction of two cells or 
due to indirect paracrine eﬀ  ects, a co-culture approach 
utilizing two interlocking combs was developed [16]. In 
this paradigm each cell type is cultured on an individual 
silicon comb and cell behavior and fate are assessed while 
combs are interlocked or when separated at known 
micro  meter scale distances. Th  is biomaterials strategy 
can spatially resolve the distance of relevant cell-cell 
commu  nications, but unlike the cell trap and microwell 
technology it is diﬃ     cult to reliably study cell-cell 
interactions at the pair level and the approach is limited 
to adherent cell types.
Elucidating cell-extracellular matrix communications
In addition to cell-cell interactions, aSC fate is modiﬁ  ed 
by interactions with the ECM. Upon injury and aging or 
during disease progression the matrix composition is 
Figure 1. The satellite cell niche. Adult stem cells, such as skeletal 
muscle satellite cells, engage in bidirectional communication with 
the surrounding niche to maintain tissue homeostasis. Pax7 (green) 
expressing satellite cells receive direct biophysical and biochemical 
cues from the multinucleated (blue) skeletal muscle fi  bers (black) they 
sit on top of and the laminin (red) containing basement membrane 
with associated growth factors and cytokines surrounding each fi  ber 
and encasing the stem cell. This confocal image of a muscle cross-
section further illustrates the architecture of the resting niche, which 
poses an additional level of regulation on stem cells.
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and aSCs can gain direct exposure to ECM ligands they 
were previously sheltered from. Identiﬁ  cation of putative 
ECM ligands present in resting and activated tissue and 
their impact on aSC behavior and fate is enabled by 
recent advances utilizing robotic spotting to print single 
and combinations of ECM ligands as arrays and subse-
quently culture and follow the fate of exposed cells 
[17,18]. Using this type of unbiased throughput approach 
can greatly advance our basic understanding of cell 
regulation by the matrix in the niche as well as to provide 
a catalogue of matrix-mediated cellular outputs that can 
be used to direct stem cell fate.
Standard tissue culture protocols typically supplement 
growth factors and cytokines in the soluble media milieu, 
while in tissues these secreted morphogens are most 
commonly presented to cells tethered to the ECM [19]. 
Covalent attachment of secreted growth factors to 
biomaterial surfaces demonstrated improved stability of 
labile proteins and persistent signaling resulting in long-
term maintenance of signaling without the requirement to 
supply additional protein [20-23]. In addition to protein 
stabilization, mode of ligand presentation (soluble versus 
tethered) was shown to have profoundly divergent eﬀ  ects 
on cell fate underlying the relevance of this distinction [20-
22,24,25]. Studies investigating ligand presentation and 
assessing how the mode of presentation inﬂ  uences cell fate 
promise not only to advance our basic under  standing of 
aSC regulation, but also to aid researchers in the smart 
design of culture conditions to promote a desired fate.
As described above, the ECM can directly modulate 
aSC behavior in the niche through direct receptor-ligand 
interactions. In addition, the density, ﬁ  ber alignment and 
porosity of the ECM can impart spatial inﬂ  uence over 
cells to dictate cell shape, an aspect which is progressively 
gaining needed attention [26]. For example, cells cultured 
on micropatterned ECM islands with the same ligand 
density but with diﬀ  erent surface area generate distinct 
spreading phenotypes resulting in marked cell shapes 
(rounded versus spread), which impose impressive 
inﬂ   uence over cell viability [27]. More recently, the 
molecu  lar mechanisms and signaling pathways driving 
cell shape-mediated eﬀ  ects on stem cell populations have 
been described [28,29]. Importantly, during wound 
healing and disease progression, tissues undergo pro-
found alterations in the identity and organization of the 
ECM, whose cellular and molecular eﬀ  ects are a topic of 
intense investigation. Niche architectural eﬀ  ects confer a 
unique dimension of aSC regulation by the ECM and 
warrant greater focus by stem cell researchers.
Investigating cell-matrix interplay
Imagine pulling a string to turn on or oﬀ   a lamp. Typically 
the string is attached to something stationary and stiﬀ   
allowing you to generate resistance and activate the 
switch. Imagine instead that the string is attached to 
something soft like putty; the more you pull the string, 
the more the soft putty will stretch preventing force 
generation or activation of the light bulb. Adherent cells 
are constantly assessing their microenvironment by mak-
ing contact with and pulling at the ECM. Cells pulling on 
adhesion ligands attached to a stiﬀ   as opposed to a soft 
matrix experience cytoskeletal reorganization resulting 
in distinct intracellular signaling that can profoundly 
alter cell fate [30-32]. Th   us, the mechanical properties of 
the niche, a biophysical cue, add yet another level of 
regulation imposed by the ECM.
First demonstrated using immortalized cell lines [33], 
the ability of matrix stiﬀ  ness to regulate cell fate is now 
widely accepted. In a groundbreaking study exploring the 
impact of substrate rigidity on stem cell fate, mesen-
chymal stem cells were shown to diﬀ  erentiate into bone, 
muscle or brain when cultured on polyacrylamide sub-
strates mimicking the mechanical properties of each 
tissue [34]. Since then, a similar biomimetic approach to 
tune the culture substrate to the stiﬀ  ness of the endoge-
nous tissue has been used to encourage lineage-speciﬁ  c 
diﬀ  erentiation to additional multipotent stem cells, such 
as neural progenitors, and to culture ES and iPS cell 
colonies long term without loss of stemness in the 
absence of the ﬁ  broblast feeder layer [35-37]. Notably, 
soluble factors present in culture media typically act 
together with the culture matrix to regulate cell fate and 
these interactions should be considered when drawing 
conclusions. Also, in contrast to standard tissue culture 
plastic, porous matrices (polyacrylamide, PEG) permit 
diﬀ   usion of soluble molecules to both the apical and 
basal cell surfaces, and decoupling the eﬀ  ects of substrate 
stiﬀ  ness from bidirectional diﬀ  usion is still a challenge.
Unlike ES and iPS cells, prospectively isolated aSCs, such 
as skeletal muscle satellite cells, are notoriously diﬃ   cult to 
expand in culture due to their natural inclina  tion to 
diﬀ  erentiate upon exposure to rigid tissue culture plastic 
[38]. Satellite cells were ﬁ  rst  identiﬁ   ed by electron 
microscopy according to their anatomic location and des-
cribed as a mononucleated cell that resides atop multi-
nucleated postmitotic skeletal ﬁ  bers and beneath a thin 
basement membrane (Figure 1) [39]. Despite the current 
knowledge that satellite cells are responsible for the 
remarkable ability of postnatal skeletal muscle tissue to 
regenerate in response to injury, aging and disease [38,40-
46], surprisingly little is known about the compo  nents of 
the niche or the extrinsic regulation imposed by the niche 
on satellite cell fate. However, recently developed strategies 
to prospectively isolate satellite cells to relatively high 
purity [38,41-46] in con  junction with robust in vivo 
functional assays of muscle stem cell fate [9,46] render the 
satellite cell ready for interro  gation in culture.
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fate, freshly isolated and FACS (ﬂ  uorescence activated 
cell sorting) enriched muscle stem cells (MuSCs) were 
cultured on PEG hydrogels with diﬀ  ering  mechanical 
proper  ties but constant ligand density [9]. Timelapse 
videos of MuSC clonal division within microwells were 
automatically analyzed using the Baxter algorithm and 
revealed improved survival when MuSCs were cultured 
on substrates that mimic the mechanical properties of 
skeletal muscle tissue. Noninvasive bioluminescence 
imaging of luciferase-expressing MuSCs transplanted 
intra  muscularly into mice after culture on hydrogels of 
varied stiﬀ  ness demonstrated that culture on a muscle 
biomimetic substrate provides the optimal condition to 
maintain ‘stemness’ long term (Figure 2). Further, an in 
vivo functional assay showed deﬁ   nitively that MuSCs 
cultured on pliant hydrogel could self-renew in culture 
while those propagated on plastic lost self-renewal 
potential in as few as 2 days. Critical to the conclusions 
drawn in these studies is the use of freshly isolated aSCs 
in combination with functional assays in mice to validate 
all culture observations; an experimental paradigm that 
sets the bar for future applications of biomaterial 
approaches to study stem cell fate.
In conclusion, two-dimensional biomaterial approaches 
are exceptionally well suited to study the cellular and 
molecular mechanisms governing stem cell fate regula-
tion by the immediately opposing niche as well as the 
greater surrounding microenvironment. Tunable synthetic 
polymer platforms oﬀ  er the ﬂ  exibility to study stem cell 
fate in response to simple or complex combinations of 
putative niche parameters. In addition, these systems are 
highly amenable to time-lapse microscopy analysis and 
with recently developed strategies to automatically 
analyze cell behavior and lineage relationships, it is now 
feasible to evaluate the vast amounts of data generated by 
such studies [9,11,47,48]. Th   e success of two-dimensional 
biomaterials approaches to study stem cell regulation in 
culture is contingent on the availability of markers and/or 
behaviors that accurately predict stem cell fate in vivo 
[49]. Transgenic reporter animals used for prospective 
isolation of aSC populations can be used to dynamically 
assay stem cell fate in real time and are particularly 
advan  tageous. Without robust, simple readouts it is diﬃ   -
cult to perform high-throughput analysis of aSC popu-
lations to screen for novel biochemical and biophysical 
features that regulate stem cell fate and further reﬁ  ne the 
resting, aged, injured and diseased niches. Nevertheless, 
by implementing two-dimensional biomaterials-based 
approaches to study aSC regulation, we are likely to 
expand our current diagnostic capa  bilities, enable in vivo 
modulation of aSC populations, and develop strategies to 
expand aSCs in culture for use in cell-based therapies.
Engineering three-dimensional stem cell 
microenvironments
In contrast to two-dimensional tissue culture approaches, 
many aSCs are embedded within a complex, instructive 
three-dimensional matrix, often in intimate contact with 
additional cell types and in proximity to nutrient and 
oxygen-delivering vasculature. While two-dimensional 
approaches enable well controlled interrogation of single 
putative niche elements on cell fate, the focus of three-
dimensional tissue engineering is to reconstruct the 
complex architecture of stem cells within a three-
dimensional matrix to achieve a physiologically relevant 
Figure 2. Substrate rigidity regulates muscle stem cell self-renewal in culture. A biomimetic biomaterials approach in conjunction with 
functional assays in mice demonstrated that muscle stem cell (MuSC) self-renewal can be maintained in culture if cells are propagated upon a 
substrate that recapitulates the mechanical properties of the native skeletal muscle tissue, a physical property of the stem cell niche [9]. Pliant 
culture substrates enabled propagation of additional Pax7 (green) expressing MuSCs and improved survival (middle), while culture on softer (left) or 
stiff  er (right) matrices decreased cell survival (gray) and promoted diff  erentiation. Image is courtesy of Stephane Corbel, Blau Laboratory.
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by comparing to and extending the design principles 
estab  lished in two-dimensional studies, three-
dimensional material biology has the greatest potential to 
impact our understanding of in vivo tissue function. As 
there are several excellent reviews describing the current 
technical advances in the relatively nascent ﬁ  eld of three-
dimensional tissue model generation [50-54], here we 
will focus on the challenges and potential of three-
dimensional matrix biology.
Challenges of three-dimensional culture models
Th   ree-dimensional biomaterials to encapsulate stem cells 
and investigate niche-mediated eﬀ   ects come with a 
number of design challenges absent in two-dimensional 
culture that must be overcome prior to use of the 
materials by the biological community. A ﬁ  rst  design 
concern is the nutrient and oxygen requirements of fully 
encapsulated stem cells [55,56]. Hydrogel systems with 
the ﬂ  exibility to optimize matrix porosity can easily meet 
this design challenge and provide adequate energy 
requirements to maintain viability. A second criterion to 
consider is the mechanism of polymer polymerization. 
While natural matrices and some synthetic polymer 
systems spontaneously interact over time to form a three-
dimensional network, other synthetic hydrogel matrices 
rely on chemical or photo-initiators to achieve polymer 
crosslinking and have potentially toxic eﬀ  ects  on 
encapsulated cells. An additional challenge inherent to 
synthetic three-dimensional scaﬀ   olds is the need to 
design strategies permitting cell migration after encap  su-
lation. Th  is has been successfully achieved through 
incorporation of matrix metalloproteinase or other 
proteolytic cleavage sequences into the polymer sequence 
[57]. An added beneﬁ  t of polymer design is the ability to 
design scaﬀ   olds that permit migration of speciﬁ  c  cell 
types based on whether or not they secrete certain 
enzymes. A ﬁ   nal design challenge is development of 
three-dimensional polymer matrices that permit 
independent tuning of biophysical and biochemical 
parameters allowing three-dimensional culture optimiza-
tion on a cell type basis. Extending this to permit matrix 
tunability over time in a spatial and temporal manner has 
the potential to enable exquisite study of stem cell fate 
changes as they may occur during disease progression 
[58]. Th   rough the careful design and thoughtful 
characterization of the parameters described above it is 
now possible to produce biomaterials that promote long-
term survival, prolifera  tion and diﬀ  erentiation of stem 
cells in three dimensions.
Establishing the eff  ects of dimensionality
One of the most exciting research areas enabled by three-
dimensional biomaterials technology is the ability to 
determine the behavioral and molecular eﬀ  ects of dimen-
sionality. While standard two-dimensional approaches 
essentially deﬁ   ne the apical and basal surface of the 
cultured cells, three-dimensional culture provides a 
situation wherein the cell actively directs its own polarity. 
By comparing cell behavior in three dimensions to that in 
two dimensions it is feasible to probe the inﬂ  uence of 
dimensionality on cultured cells. However, it is critically 
important to consider the limitations of the system 
employed, asan  observed eﬀ   ect could be due to a 
constraint in the culture system and not dimensionality 
per se. For example, a diﬀ   erence in cell behaviour or 
function may be confounded by a lack of appropriate 
growth factor and nutrient diﬀ   usion through three-
dimensional biomaterials. Culture systems designed to 
overcome this common diﬀ  usion barrier in the three-
dimensional culture setting are needed to draw meaning-
ful conclusions about the eﬀ  ects of dimensionality on cell 
fate [59].
Recent studies exploring the eﬀ  ect of dimensionality on 
cell behavior and fate have revealed several surprising 
ﬁ  ndings. For example, a comparison of breast tumor cells 
lacking or re-expressing HOXA9, a novel breast tumor 
suppressor gene, exhibited no diﬀ  erence in cell growth 
when assayed in two dimensions, but when the cells were 
embedded within a three-dimensional reconstituted 
basement membrane (mimicking the in vivo micro-
environ  ment) distinct diﬀ   erences in proliferation were 
observed [60]. Th   ese studies underscore the importance 
of studying cells in the context of a three-dimensional 
tissue-like structure in order to fully realize the eﬀ  ects of 
a genetic (intrinsic) alteration. Further, when reconstruct-
ing a three-dimensional stem cell microenvironment it 
should not be assumed that observations made in two 
dimensions will necessarily translate into a similar eﬀ  ect 
in three dimensions. Often additional tweaking of bio-
physical and biochemical parameters in three dimensions 
is necessary to optimize a desired stem cell behavior 
[19,36,61]. Arguably, one of the most interesting 
dimensionality-related discrepancies arose from studies 
on cell migration. Until now, models of cell migration 
were derived from two-dimensional studies of cell 
motility and led to an understanding that migration is 
intimately linked to the formation of distinct sites of cell 
attachment containing paxillin, vinculin, actin, focal 
adhesion kinase as well as other structural and signaling 
molecules necessary for focal adhesion formation and 
force generation. However, in three dimensions it was 
noted that migration occurs in the absence of distinct 
focal adhesion formation and the characteristic molecules 
observed in focal adhesion aggregates in two dimensions 
(paxillin, vinculin, and so on) were found diﬀ  usely 
localized throughout the cell during three-dimensional 
movement [62]. Similar comparisons of two-dimensional 
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reveal similar discrepancies and contribute to our under-
standing of how dimensionality regulates stem cells.
Potential of three-dimensional matrix biology
Th   ree-dimensional biomaterials enable reconstruction of 
physiological models of tissue matrix scaﬀ  olds and their 
accompanying cell types in both homeostatic and disease 
states [19]. Not only can they be used to expand our basic 
knowledge of stem cell regulation by the microenviron-
ment, but these models can also facilitate identiﬁ  cation 
of therapeutics targeting the stem cell niche to treat aged, 
injured and diseased tissues. While it is unreasonable to 
expect three-dimensional models to mimic the native 
tissue down to molecular detail, by recapitulating certain 
fundamental physiological functions, such models can be 
used to study how perturbations to systems such as the 
human airway wall, the lung or liver eﬀ  ect  speciﬁ  c 
functional outcomes to investigate the eﬃ   cacy and mode 
of action of novel and currently prescribed medications 
[63-65]. In addition, these models can be used to test the 
toxicity of drugs intended for use in patients. Finally, 
three-dimensional biomaterials can be expected to play a 
substantial role in directing tissue regeneration or even 
act as replacement tissues as described in the following 
section.
Clinical translation of engineered 
microenvironments
Th   e integration of bioengineering approaches with stem 
cell biology has the potential to substantially change the 
practice of medicine as we know it today. While 
hematopoietic cell transplantation therapies have been 
used in the clinic for more than a decade to resolve blood 
malignancies, most solid tissues are precluded from 
treatment with cell-based therapies to regenerate defects 
and restore function. Several complicated factors lend to 
this discrepancy, but the lack of suitable strategies to 
expand isolated aSCs or to robustly diﬀ  erentiate ES or 
iPS cells into a single tissue-speciﬁ  c lineage is a major 
limitation to the progress of cell-based therapies. Using 
two-dimensional or three-dimensional biomaterials 
approaches, it is realistic to imagine that in the near 
future we will identify simple strategies based on smart 
design principles to expand aSCs and direct ES and iPS 
cell fate, enabling cell-based regenerative therapeutics.
After injury, or as result of aging or disease, the 
homeostatic microenvironment can undergo substantial 
remodeling and reconstruction and, consequently, render 
the environment ill-instructive for resident tissue-speciﬁ  c 
aSCs. For example, it is hypothesized that extrinsic 
changes to the satellite cell microenvironment prevent 
eﬀ   ective skeletal muscle regeneration rather than in-
trinsic changes to the satellite cell itself during aging [66]. 
As an alternative to cell based therapies, studies suggest 
that simply providing an instructive cell-free scaﬀ  old to 
artiﬁ  cially modify the microenvironment and direct the 
aSCs residing in tissue could prove useful to regenerate 
damaged tissue [67]. Th  is approach was ﬁ  rst developed 
and utilized in the repair of critical sized defects in bone 
through the use of allogeneic demineralized bone matrix, 
a US Food and Drug Administration approved product, 
and has now been extended to many other tissue types 
[68,69]. For example, cell-free scaﬀ  old-based strategies 
are already used in the clinic to repair open skin wounds 
on war victims [70]. By focusing on biochemical and 
biophysical parameters governing stem cell fate decisions 
(that is, directed migration, proliferation, diﬀ  erentiation, 
and so on), materials impregnated with signaling mole-
cules designed for release in a temporally and spatially 
regulated manner are a viable option to modulate cell fate 
and promote repair over time within the intact patient 
[71].
Regenerative medicine using cell-free scaﬀ  olds relies 
on the patient’s own cells to migrate into and repopulate 
the acellular scaﬀ  old (Figure 3). To overcome this poten-
tial challenge, strategies combining synthetic or natural 
matrices repopulated with cell types required for long-
term function of the replacement tissue are being 
developed. For example, large cartilage defects resulting 
from injury or aging are notoriously diﬃ   cult to repair. 
Use of a nanoﬁ  brous scaﬀ  old seeded with human mesen-
chymal stem cells (which evade the immune response) 
demonstrated the ability of a bioengineering approach to 
repair large cartilage defects in swine while restoring 
smooth cartilage at the surface and withstanding use-
associated compression force [72]. Similarly, corneal 
function was restored in patients aﬄ   icted by debilitating 
burns using autologous limbal stem cells embedded in 
ﬁ  brin gels [73].
A major challenge in the clinic is the availability of 
donor tissue for transplantation into patients with critical 
organ failure. A tissue-engineering approach based upon 
the principle of designing stem cell microenvironments 
that incorporate the cell types, signaling cues and 
structure required for long-term physiological function 
and incor  poration in a living patient has the potential to 
sub  stantially reduce the current reliance on organ donors 
to provide tissues to patients in critical need. Th  ough 
generation of functional three-dimensional organs is an 
extraordinary challenge, several research groups are 
actively pursuing this goal and the literature is already 
repleat with successes. To overcome the challenge of lost 
bladder function in young patients aﬄ   icted with disease 
rendering malfunction, researchers utilized a bioengi-
neer  ing approach to construct collagen scaﬀ  olds in the 
likeness of the human bladder. To ensure proper long-
term function and to reduce the possibility of tissue 
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urothelial and muscle cells isolated from the patient prior 
to transplantation. Follow-up studies 2 years following 
transplantation concluded that the bioengineered bladders 
had not only maintained architecture, but were also still 
fully functional in the patient recipients [74]. Organ trans-
plantation is typically accompanied by use of immune 
suppression treatment to reduce the incidence of immune 
rejection. To improve transplantation success, several 
researchers are adopting a bioengineering approach that 
entails decellularizing donor tissue (to remove the major 
histocompatibility complex (MHC) component) with a 
gentle, multistep detergent treatment that leaves the 
matrix scaﬀ   old intact and permits recolonization with 
patient derived cells. Th  is approach has been used 
successfully to treat a patient suﬀ   ering from broncho-
malacia (loss of airway function). Trans  plant of a 
decellularized donor trachea repopulated with epithelial 
cells and chondrocytes from patient-derived mesenchymal 
stem cells led to successful long-term repair of the airway 
defect and restoration of mechanical properties [75]. 
Finally, a recent study demonstrated the possibility of 
using a bioengineering approach to construct corporal 
tissue to facilitate penile reconstruc  tion. In a multistep, 
dynamic process the three-dimensional corporal tissue 
was engineered from a naturally derived collagen matrix 
reseeded with autologous cells and trans  planted into 
rabbits with excised corpora. Amazingly, the bio  engi-
neered phallus was structurally similar to the native tissue 
and function was demonstrated by successful impreg-
nation of female rabbits with the engineered tissue [76]. 
Together these examples exemplify the potential impact 
that material science will have on the treatment of human 
disease in the not so distant future.
Conclusion
Both two-dimensional and three-dimensional biomaterials 
approaches are changing the way scientists think about 
the stem cell microenvironment and are providing 
strategies to regulate the fate of prospectively isolated 
stem cells in culture and of stem cells residing in intact 
tissues. More importantly, current biomaterials tech  nolo-
gies and the inevitable future technological advances in 
the ﬁ  eld provide a novel toolbox for stem cell biologists 
to investigate the impact of niche biochemical and 
biophysical properties in unprecedented ways. Th  ese 
engineering approaches can be extended to all pros-
pectively isolated stem cell populations for the purpose of 
elucidating the mechanisms governing their regulation.
To accelerate the impact of biomaterials towards the 
treatment of human disease, it is essential to incorporate 
in vivo functional assays as a standard practice to validate 
observations made in culture. Furthermore, by placing 
more emphasis on human stem cells and their niche 
regulation, we can advance the translation of material-
based therapeutics from the bench to the bedside. 
Bioengineering approaches to study the stem cell micro-
environment have the potential to revolutionize regener  a-
tive medicine by providing physicians with tools to 
regulate resident aSC behavior (that is, self-renewal, 
diﬀ  er  en  tiation, migration) in patients, cells for cell-based 
therapies, and perhaps even bioengineered organs to 
replace defective tissues. Ultimately, the active colla-
boration of engineers, biologists, physicians, chemists, 
computational scientists and physicists towards the goal 
of understanding the niche, how it regulates stem cell fate 
and how it changes with aging, injury and disease will 
allow us to harness this knowledge and generate novel 
regenerative medicine therapeutics.
Figure 3. Alternative approaches to functional organ replacement. Organ transplant is plagued by lack of available tissue, the short window 
of tissue viability prior to transplant and graft rejection after transplant. A new bioengineering approach promises to overcome many of these 
challenges in the near future. Donor tissue, such as liver (A), is decellularized (B) through a multistep process that leaves the extracellular matrix 
scaff  old intact. The matrix is then repopulated with tissue-specifi  c cells that are compatible to the patient - for example, by diff  erentiating patient-
derived iPS cells into hepatocytes. Resultant tissues can either be studied in culture to gain insight into tissue function (C) or used for transplant in 
the clinic (D). Since this approach capitalizes on the remaining matrix scaff  old and removes donor cells, tissues that would normally be discarded 
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